GO
Loading...

Regulations

More

  • Merck's Singulair Scrutinized for Safety by FDA Thursday, 27 Mar 2008 | 11:35 AM ET

    U.S. regulators on Thursday said they are probing a possible connection between Merck's Singulair asthma drug and suicidal behavior.

  • FSA to Get Tougher after Northern Rock Wednesday, 26 Mar 2008 | 5:01 AM ET

    Britain's financial watchdog will boost its supervision of top banks after admitting on Wednesday that its supervision of Northern Rock was unacceptable and failed to highlight the mortgage lender's vulnerability.

  • Fidelity anti-money laundering unit probed? Friday, 14 Mar 2008 | 9:56 AM ET

    A federal grand jury and the Securities and Exchange Commission have been investigating the anti-money laundering practices of Fidelity Investments, according to a report in the Boston Business Journal.

  • Amgen, J&J Drug Benefits Upheld by FDA Panel Thursday, 13 Mar 2008 | 4:51 PM ET
    The sign outside Amgen Inc.'s entrance. Thousand Oaks, Calif.

    Scientists advising the Food and Drug Administration said anemia drugs sold by Amgen and Johnson & Johnson should be allowed to stay on the market for chemotherapy patients.

  • Spitzer's Successor Is NY's First Black Governor Wednesday, 12 Mar 2008 | 12:24 PM ET
    David Paterson

    With the resignation of Eliot Spitzer, Lt. Governor David A. Paterson will become New York's first African-American governor and the first-ever legally blind governor in U.S. history.

  • Spitzer's Successor Would Be NY's First Black Governor Tuesday, 11 Mar 2008 | 4:52 PM ET
    David Paterson

    If Eliot Spitzer resigns, he would be succeeded by Lt. Governor David A. Paterson, who would become New York's first African-American governor and the first who is legally blind.

  • XM-Sirius: Rep. Gene Green Responds Friday, 29 Feb 2008 | 7:14 PM ET

    He’s been the merger’s staunchest opponent. Now the Democrat from Texas explains his position to Cramer.

  • Lily Shares Fall After FDA Rejects Long-Acting Zyprexa Thursday, 28 Feb 2008 | 10:13 AM ET
    Eli Lilly's drug Zyprexa.

    U.S. regulators have rejected a long-acting injectable form of Eli Lilly and Co's blockbuster schizophrenia drug Zyprexa, the company said Thursday, sending its shares down almost 2 percent.

  • XM-Sirius Merger: Cramer Names Names Monday, 25 Feb 2008 | 7:23 PM ET

    The Mad Money host calls out the members of Congress who are blocking the XM-Sirius merger from going through.

  • FDIC Chair:  More Mortgage Transparency Needed Monday, 25 Feb 2008 | 8:53 AM ET

    The head of the organization that insures the nation's commercial banks says there's a need for more transparency in reporting the fortunes and misfortunes of the home mortgage market.

  • Anheuser, Miller Face Caffeinated Drinks Probe Thursday, 21 Feb 2008 | 5:30 AM ET

    Brewers Anheuser-Busch and Miller Brewing said on Wednesday that several U.S. state Attorneys General have demanded information on how they market and sell caffeinated alcoholic drinks.

  • Justices Make It Harder to Sue Medical Device Makers Wednesday, 20 Feb 2008 | 11:19 AM ET

    The Supreme Court on Wednesday made it harder for consumers to sue manufacturers of federally approved medical devices.

  • Australia, US Strike Open-Skies Pact Friday, 15 Feb 2008 | 12:21 AM ET

    Australia and the United States have agreed to drop restrictions on lucrative trans-Pacific flight routes between the two countries, Australia's government said on Friday.

  • Allergan, Medicis Shares Drop on Botox Probe Friday, 8 Feb 2008 | 12:27 PM ET

    Regulators said they're reviewing the safety of Allergan's Botox and a competing product after reports of deaths and serious reactions in some patients.

  • U.S. Probes Stock Sales By SocGen Board Member Monday, 4 Feb 2008 | 2:13 PM ET

    The U.S.  is looking into stock sales by a member of French bank Societe Generale's board shortly before the bank announced billions of dollars in losses by a single trader.

  • Singapore GIC Prepared to Adjust UBS Terms: FT Monday, 4 Feb 2008 | 12:57 AM ET

    The Government of Singapore Investment Corp is prepared to adjust the terms of its deal to buy 9 percent of UBS to help the Swiss bank win shareholder approval, its deputy chairman was quoted as saying on Monday.

  • Microsoft/Yahoo Deal Poses Antitrust Issues: Google Sunday, 3 Feb 2008 | 3:16 PM ET

    Google Inc fired back Sunday at Microsoft's $44.6 billion bid to acquire Yahoo, accusing Microsoft of seeking to extend its computer software monopoly deeper into the Internet realm.

  • UBS Facing Subprime Banking Investigations: WSJ Sunday, 3 Feb 2008 | 2:15 PM ET

    U.S. government prosecutors are investigating whether Swiss banking giant UBS misled investors by reporting inflated prices of mortgage-backed securities it held despite knowing those valuations had eroded, the Wall Street Journal said Saturday.

  • Merrill Lynch Sued by Massachusetts Over Subprime Friday, 1 Feb 2008 | 3:50 PM ET

    The top securities regulator in Massachusetts said he has filed civil charges against Merrill Lynch, accusing the brokerage of selling unsuitable subprime mortgage-related securities to the city of Springfield.

  • FDA to Pfizer: Toughen Warning on Chantix Friday, 1 Feb 2008 | 3:44 PM ET

    U.S. regulators on Friday said Pfizer's anti-smoking drug Chantix appears increasingly likely to be linked to serious psychiatric behavior, and called for stronger label warnings.

Most Popular Video

Thursday, 17 Apr 2014 | 12:58 PM ET

The FMHR traders reveal their final trades.

Friday, 18 Apr 2014 | 11:00 AM ET

Are economic growth expectations too high? CNBC's Jeff Cox explains.

Friday, 18 Apr 2014 | 12:00 PM ET

CNBC's Stephanie Landsman discusses how the luxury rental boom isn't confined to New York City and its boroughs, but that developers are seeing new opportunities in New Jersey.